MicroRNAs as B-cell lymphoma biomarkers

Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manterola L, Fernandez-Mercado M, Larrea E, Goicoechea I, Arestin M, Armesto M, Hernandez L, Lawrie CH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/16162ae744164af9afa9f88937cee74f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:16162ae744164af9afa9f88937cee74f
record_format dspace
spelling oai:doaj.org-article:16162ae744164af9afa9f88937cee74f2021-12-02T03:23:49ZMicroRNAs as B-cell lymphoma biomarkers1179-9889https://doaj.org/article/16162ae744164af9afa9f88937cee74f2015-02-01T00:00:00Zhttp://www.dovepress.com/micrornas-as-b-cell-lymphoma-biomarkers-peer-reviewed-article-BLCTThttps://doaj.org/toc/1179-9889 Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK; 3Ikerbasque, Basque Foundation for Science, Bilbao, Spain Abstract: B-cell lymphomas represent a group of more than 35 recognized mature B-cell neoplasms differentiated largely on the basis of immunohistochemical staining patterns that are often challenging to accurately diagnose. Despite having been only formally recognized just over 10 years ago, microRNAs (miRNAs) have become one of the trendiest topics in biology. Dysregulation of miRNAs is a ubiquitous feature of cancer in general, including B-cell lymphomas. Many of the miRNAs aberrantly expressed in B-cell lymphomas also play a crucial regulatory role in normal hematopoietic function. MiRNAs show great potential as novel biomarkers of cancer, as they can differentiate cancers according to diagnosis and developmental stage, even discriminating between cancers that are poorly separated histologically. Furthermore, they can be robustly measured from routinely prepared formalin-fixed paraffin-embedded biopsy material and biological fluids such as blood. Here, we consider the identity, function, and biomarker potential of miRNAs in B-cell lymphomas and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. Keywords: microRNA, lymphoma, biomarker, B-cell Manterola LFernandez-Mercado MLarrea EGoicoechea IArestin MArmesto MHernandez LLawrie CHDove Medical PressarticleDiseases of the blood and blood-forming organsRC633-647.5ENBlood and Lymphatic Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 25-34 (2015)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the blood and blood-forming organs
RC633-647.5
spellingShingle Diseases of the blood and blood-forming organs
RC633-647.5
Manterola L
Fernandez-Mercado M
Larrea E
Goicoechea I
Arestin M
Armesto M
Hernandez L
Lawrie CH
MicroRNAs as B-cell lymphoma biomarkers
description Lorea Manterola,1 Marta Fernandez-Mercado,1 Erika Larrea,1 Ibai Goicoechea,1 María Arestin,1 María Armesto,1 Luiza Hernandez,1 Charles H Lawrie1,2,3 1Oncology Area, Biodonostia Research Institute, San Sebastián, Spain; 2Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK; 3Ikerbasque, Basque Foundation for Science, Bilbao, Spain Abstract: B-cell lymphomas represent a group of more than 35 recognized mature B-cell neoplasms differentiated largely on the basis of immunohistochemical staining patterns that are often challenging to accurately diagnose. Despite having been only formally recognized just over 10 years ago, microRNAs (miRNAs) have become one of the trendiest topics in biology. Dysregulation of miRNAs is a ubiquitous feature of cancer in general, including B-cell lymphomas. Many of the miRNAs aberrantly expressed in B-cell lymphomas also play a crucial regulatory role in normal hematopoietic function. MiRNAs show great potential as novel biomarkers of cancer, as they can differentiate cancers according to diagnosis and developmental stage, even discriminating between cancers that are poorly separated histologically. Furthermore, they can be robustly measured from routinely prepared formalin-fixed paraffin-embedded biopsy material and biological fluids such as blood. Here, we consider the identity, function, and biomarker potential of miRNAs in B-cell lymphomas and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. Keywords: microRNA, lymphoma, biomarker, B-cell 
format article
author Manterola L
Fernandez-Mercado M
Larrea E
Goicoechea I
Arestin M
Armesto M
Hernandez L
Lawrie CH
author_facet Manterola L
Fernandez-Mercado M
Larrea E
Goicoechea I
Arestin M
Armesto M
Hernandez L
Lawrie CH
author_sort Manterola L
title MicroRNAs as B-cell lymphoma biomarkers
title_short MicroRNAs as B-cell lymphoma biomarkers
title_full MicroRNAs as B-cell lymphoma biomarkers
title_fullStr MicroRNAs as B-cell lymphoma biomarkers
title_full_unstemmed MicroRNAs as B-cell lymphoma biomarkers
title_sort micrornas as b-cell lymphoma biomarkers
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/16162ae744164af9afa9f88937cee74f
work_keys_str_mv AT manterolal micrornasasbcelllymphomabiomarkers
AT fernandezmercadom micrornasasbcelllymphomabiomarkers
AT larreae micrornasasbcelllymphomabiomarkers
AT goicoecheai micrornasasbcelllymphomabiomarkers
AT arestinm micrornasasbcelllymphomabiomarkers
AT armestom micrornasasbcelllymphomabiomarkers
AT hernandezl micrornasasbcelllymphomabiomarkers
AT lawriech micrornasasbcelllymphomabiomarkers
_version_ 1718401778401148928